Digirad Corporation Appoints John W. Sayward to Its Board of Directors
March 19 2008 - 12:58PM
PR Newswire (US)
POWAY, Calif., March 19 /PRNewswire-FirstCall/ -- Digirad
Corporation (NASDAQ:DRAD), a leading provider of medical diagnostic
imaging products and services to physicians' offices, hospitals and
imaging centers, today announced its board of directors has
appointed veteran healthcare executive John W. Sayward director and
audit committee chairman, effective immediately. Mr. Sayward, 56,
has more than 30 years of finance, accounting, operational and
administrative experience in the healthcare industry, and has
previously served on the board of a public pharmaceuticals company.
He replaces Raymond Dittamore, 65, who resigned from the board and
has retired from business. Mr. Dittamore joined the Digirad board
in March 2004 and served as chairman of the audit committee.
Digirad Chairman R. King Nelson said, "John Sayward's extensive
operational and financial management background in healthcare and
his experience in cardiology will be valuable assets to Digirad as
the Company moves forward with its Centers of Excellence expansion
strategy and focuses on accelerating its top and bottom line
growth. "We would also like to thank Ray for his many years of
providing solid guidance and support of Digirad, and we wish him
the very best," King added. From September 2005 to January 2007,
Mr. Sayward was a partner at Nippon Heart Hospital, LLC (NHH), a
healthcare management company, formed to partner with leading
cardiologists to improve cardiovascular care and build and manage
cardiovascular-care hospitals in Japan. While at NHH, Mr. Sayward
helped develop relationships with cardiology leaders, government
officials and hospital administrators, managed NHH's strategic
business plan and evaluated alternatives for financing that plan.
From 2002 to 2005, he was executive vice president and chief
financial officer of LMA North America Inc., a medical device
company, where he managed the company's operations, quality and
human resources functions and was a key player in the company's
initial public offering. Prior to 2002, he was chief financial
officer and a director of SICOR, Inc., a $2.5 billion
pharmaceuticals company that was acquired by Teva Pharmaceuticals.
As a senior executive at SICOR he made significant contributions to
a highly successful business turnaround and managed a number of
corporate-level transactions including the divestiture of a
subsidiary, an acquisition and secured financing for strategic
expansion. Mr. Sayward received his undergraduate degree from
Northwestern University and a master of management degree from
Kellogg School of Management at Northwestern University. About
Digirad Corporation Digirad provides diagnostic medical imaging
products and services to physicians' offices, hospitals and imaging
centers for cardiac, vascular, and general imaging applications.
Digirad's Cardius XPO line of nuclear imaging cameras use patented
solid-state technology and unique multi (single, dual, triple) head
design for superior performance and advanced features for sharper
digital images, faster processing, compact size, lighter weight for
portability, ability to handle patients up to 500 pounds, and
improved patient comfort compared to standard nuclear cameras.
Digirad's 2020tc general-purpose nuclear imager has a small
footprint and may also be configured for fixed or mobile use to
supplement primary imaging. Digirad's installed base of equipment
exceeds 450 systems; in addition, a mobile fleet of more than 120
nuclear and ultrasound imaging systems is being used in 22 states,
primarily in the eastern, midwestern and southwestern United
States. For more information, please visit http://www.digirad.com/.
Digirad(R), Digirad Imaging Solutions(R), and Cardius(R) are
registered trademarks of Digirad Corporation. Forward-Looking
Statements Digirad cautions that statements included in this press
release that are not a description of historical facts are
forward-looking statements. You can identify these statements by
the fact that they do not relate strictly to historical or current
facts and use words such as "anticipate," "estimate," "expect,"
"project," "intend," "plan," "believe" and other words and terms of
similar meaning in connection with a discussion of future operating
or financial performance or events. Examples of such statements
include statements regarding the Company's centers of influence
expansion strategy and top and bottom line growth projections. The
inclusion of these and other forward-looking statements should not
be regarded as a representation by Digirad that any of its plans
will be achieved. Actual results may differ materially from those
set forth in this press release due to the risks and uncertainties
inherent in Digirad's business, market conditions, overall business
prospects and operations; and other risks detailed in Digirad's
filings with the U.S. Securities and Exchange Commission, including
its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q,
Form 8-K and other reports. Given these uncertainties, readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date hereof. All
forward-looking statements are qualified in their entirety by this
cautionary statement and Digirad undertakes no obligation to revise
or update this press release including the forward-looking
statements contained herein to reflect events or circumstances
after the date hereof or to update the reasons actual results could
differ materially from those anticipated in these forward-looking
statements, even if new information becomes available in the
future. Investor Contact: Company Contact: Dan Matsui Mark Casner
Allen & Caron CEO 949-474-4300 858-726-1600 DATASOURCE: Digirad
Corporation CONTACT: Investors, Dan Matsui of Allen & Caron,
+1-949-474-4300, , for Digirad; or Mark Casner, CEO of Digirad,
+1-858-726-1600, Web site: http://www.digirad.com/
Copyright
Digirad (NASDAQ:DRAD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Digirad (NASDAQ:DRAD)
Historical Stock Chart
From Jul 2023 to Jul 2024